Javascript must be enabled to continue!
Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.M. Pfau, Civil Hospital Karachi
View through CrossRef
Objectives: To determine the frequency of vaccination status in patients with SARS-CoV-2 infection
Methods: This case-control study was conducted at Dr Ruth KM Pfau Civil Hospital Karachi, Pakistan between September 2021 to October 2021. All patients who had positive PCR on nasopharyngeal swab for SARS-CoV-2 infection were included. Information regarding vaccination status and brand of vaccination administered and duration between the last dose of vaccine and positive PCR was noted. The disease status of patients was classified on admission into severe and non-severe disease.
Results: Study included 143 patients, out of which 58 (40.6%) were males and 85 (59.4%) were females. Majority of our patients (78.3%) were unvaccinated. Frequency of Severe SARS-CoV-2 Infection in fully vaccinated patients was less than in unvaccinated patients. The odds of developing severe COVID infection in unvaccinated patients versus vaccinated was 8.55 times higher (OR = 6.23, 95% CI 2.58-28.35). Proportion of vaccinated females was less as compared to males. Significant differences were found in severity between hypertension (p<.001), diabetes (<.001) and age (p<.001).
Conclusion: The frequency of SARS-CoV-2 infection was greater in unvaccinated patients. The odds of developing severe COVID infection in unvaccinated patients versus vaccinated was 8.55 times higher.
doi: https://doi.org/10.12669/pjms.38.8.5733
How to cite this:Rasheed T, Ali FS, Zuberi BF, Sadaf R. Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.M. Pfau, Civil Hospital Karachi. Pak J Med Sci. 2022;38(8):---------. doi: https://doi.org/10.12669/pjms.38.8.5733
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Pakistan Journal of Medical Sciences
Title: Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.M. Pfau, Civil Hospital Karachi
Description:
Objectives: To determine the frequency of vaccination status in patients with SARS-CoV-2 infection
Methods: This case-control study was conducted at Dr Ruth KM Pfau Civil Hospital Karachi, Pakistan between September 2021 to October 2021.
All patients who had positive PCR on nasopharyngeal swab for SARS-CoV-2 infection were included.
Information regarding vaccination status and brand of vaccination administered and duration between the last dose of vaccine and positive PCR was noted.
The disease status of patients was classified on admission into severe and non-severe disease.
Results: Study included 143 patients, out of which 58 (40.
6%) were males and 85 (59.
4%) were females.
Majority of our patients (78.
3%) were unvaccinated.
Frequency of Severe SARS-CoV-2 Infection in fully vaccinated patients was less than in unvaccinated patients.
The odds of developing severe COVID infection in unvaccinated patients versus vaccinated was 8.
55 times higher (OR = 6.
23, 95% CI 2.
58-28.
35).
Proportion of vaccinated females was less as compared to males.
Significant differences were found in severity between hypertension (p<.
001), diabetes (<.
001) and age (p<.
001).
Conclusion: The frequency of SARS-CoV-2 infection was greater in unvaccinated patients.
The odds of developing severe COVID infection in unvaccinated patients versus vaccinated was 8.
55 times higher.
doi: https://doi.
org/10.
12669/pjms.
38.
8.
5733
How to cite this:Rasheed T, Ali FS, Zuberi BF, Sadaf R.
Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.
M.
Pfau, Civil Hospital Karachi.
Pak J Med Sci.
2022;38(8):---------.
doi: https://doi.
org/10.
12669/pjms.
38.
8.
5733
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.
org/licenses/by/3.
0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Related Results
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease
Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease
Abstract
Background
Patients with end stage renal disease (ESRD) undergoing hemodialysis are at increased risk for infection and impaired vaccina...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
INTEGRATING HEALTH, EDUCATION, AND SPORT: THE IMPACT OF SARS-COV-2 INFECTION AND COVID-19 VACCINATION ON BREASTFEEDING, NEONATAL IMMUNITY, AND EARLY PHYSICAL DEVELOPMENT
INTEGRATING HEALTH, EDUCATION, AND SPORT: THE IMPACT OF SARS-COV-2 INFECTION AND COVID-19 VACCINATION ON BREASTFEEDING, NEONATAL IMMUNITY, AND EARLY PHYSICAL DEVELOPMENT
The COVID-19 pandemic has underscored the critical role of public health education in promoting maternal and neonatal well-being. This systematic review examines the impact of SARS...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses
Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses
Aim: To analyze spike proteins of Severe Acute Respiratory Syndrome (SARS)-related coronaviruses (CoVs) for their conserved motifs, Receptor-Binding Domain (RBD), Receptor Binding...

